Liver targeting of ledipasvir via galactosylated chitosan–coated spanlastics: chemical synthesis, statistical optimization, in vitro, and pharmacokinetic evaluation
- Citation:
- Fatouh, A. M., A. H. Elshafeey, and A. A. Elbary, Liver targeting of ledipasvir via galactosylated chitosan–coated spanlastics: chemical synthesis, statistical optimization, in vitro, and pharmacokinetic evaluation, , 2021.
Abstract:
Ledipasvir is an effective direct acting antiviral agent used in the treatment of hepatitis C virus. The high price of ledipasvir was a reason for its limited provision to wide population of HCV patients.
Notes:
n/a